Shivali Gulab
Avalia Immunotherapies
Affiliations
Victoria University of Wellington, New Zealand
Technologies
Therapeutic
Indication
Allergy/Asthma
Infectious Disease
Oncology
Executive Summary
View/DownloadAvalia Immunotherapies – A synthetic immunotherapy platform for self-adjuvanting vaccines, with a unique mode of action, aiming to improve clinical outcomes for cancer, allergy and infectious disease.
